CDKN2A and Hepatic fibrosis: Elimination of senescent cells in INK-ATTAC mice or by treatment with a combination of the senolytic drugs dasatinib and quercetin reduces hepatic steatosis [17], while specific elimination of p16INK4A-expressing liver sinusoidal endothelial cells induces hepatic fibrosis and premature death [39].